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Abstract 
Background: To determine the effect of injection 
bupivacaine instillation in gall bladder fossa on 
post-op pain relief after laparoscopic 
cholecystectomy. 
Methods: In this randomized controlled trial 80 
patients, diagnosed as having gall-stones, were 
divided into 2 groups for laparoscopic 
cholecystectomy. Group A received injection 
bupivacaine instillation in gall-bladder fossa, while 
Group B did not receive any injection.  
Results:Out of 40 patients enrolled as bupivacaine 
group, 30 were female and 10 were male patients  
with mean age of 45.45 ± 9.86 years, whereas in 
control group, there were 33 female and 07 male 
patients in a total of 40 patients, and the mean age 
was 45.22 ± 11.62 years. Mean VAS scores in 
bupivacaine group at 8, 16 and 24 hrs were  4.43, 2.98 
and 1.35 respectively, while they were 6.30, 3.15 and 
1.43 in controls at 8, 16 and 24hrs respectively. VAS 
scores tended to be higher in females . Need for post-
op analgesia in 1st 8hrs was more in the 
controls(70%). The need for post-op analgesia at 
16hrs and 24hrs after surgery was almost equal in 
both groups. Post-op pain relief in 1st 8hrs was better 
in the bupivacaine group i.e. 30% vs. 15% .  
Conclusion: The early post-op VAS scores and 
pain intensity  after 8hrs is decreased with the use of 
intra-peritoneal instillation of injection Bupivacaine, 
but it offers no added benefit in terms of post-
operative pain relief and need for analgesia post-
operatively. 
Key Words: Bupivacaine, Gall bladder fossa, post-
operative pain relief, Laparoscopic Cholecystectomy.  
 
Introduction 
        Cholelithiasis is found in a large number of 
people though asymptomatic. Worldwide occurrence 
of gallstones varies from 6-20%. 1 Asymptomatic 
gallstone patients develop complications at an annual 
rate of 1-2%.2 Laparoscopic cholecystectomy (LC) is 
nowadays established as a gold standard form of 
treatment of patients with cholilithiasis. It is feasible 
and safe with high patient satisfaction even with broad 
selection criteria. Improvements may be achieved in 
postoperative pain management.3 
      Although the  post-operative pain after LC is quite 
less as compared to open cholecystectomy (OC), but 
the recent studies have shown that patients may 
experience considerable post-operative pain after LC, 
the postoperative shoulder and visceral abdominal 
pain experienced by patients still causes preventable 
distress.4 The various methods now being utilized with 
variable success in the post-operative pain 
management after laparoscopic surgery include agents 
like non-steroidal anti-inflammatory drugs (NSAIDS), 
infiltration of wound with local anesthetics (LA) and 
intermittent intra-muscular narcotics.2 Intra-peritoneal 
irrigation of the diaphragmatic surface and 
gallbladder fossa using normal saline, bupivacaine, or 
lignocaine may effectively control visceral abdominal 
pain after LC.4 
    The pain scores are lower in patients with intra-
peritoneal instillation as compared to local instillation 
or oral analgesia. Additional rescue analgesic 
treatment was significantly lower in patients with 
intra-peritoneal instillation (35%) as compared with 
those with local/ no instillation (84%). The 
combination of pre-incisional local infiltration and 
intra-peritoneal instillation of L-B 0.25% shows an 
advantage for postoperative analgesia after 
laparoscopic cholecystectomy.5 
      
Patients and Methods  
     This randomized controlled trial was conducted at 
the Surgical Unit I, Holy Family Hospital, 
Rawalpindi,from May 2010 to September 2010.Sample 
size was calculated by using WHO sample size 
calculator taking level of significance 5%,power of test 
90%,anticipated population proportion p1 = 
84%6,anticipated population proportion p2 = 35%6.The 
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Calculated sample size = 19 in each group, which is 
very small, so we have taken 40 as sample size in each 
group. 80 patients diagnosed as having gall-stones 
were grouped into 2 for laparoscopic cholecystectomy. 
Group A received injection bupivacaine instillation in 
gall-bladder fossa, while Group B did not receive any 
injection. 
     Inclusion criteria constituted age below 20-60 yrs 
and all patients with cholilithiasis on ultrasound. 
Patients with history of upper abdominal surgery/ 
upper GI malignancy/ obstructive jaundice / 
hepatobiliary pathology,bleeding diathesis/ Hepatitis 
B or C patient,hypersensitivity to the drug to be used 
in the procedure,using anticoagulants and known 
cardiac patients, were excluded .  
      The patients were randomized into 2 groups 
through a computer generated list.Group A patients 
were instilled with 20ml of 0.5% injection bupivacaine 
in gall bladder fossa just after cholecystectomy and 
Group B patients (control) were not instilled with any 
injection.Immediately after surgery all patients were 
injected Tramadol Hydrochloride in a dose of 1mg/kg 
body weight intramuscularly. Then assessed according 
to visual analogue scale for post-operative pain and 
need for post-operative analgesia 8hourly for the first 
24hours in the post anesthesia care unit. Injection 
Tramadol Hydrochloride (1mg/kg) intramuscularly 
was given if analgesia was required on 8hourly basis. 
Descriptive statistics were used to calculate mean and 
standard deviation for numerical variables i.e. age, 
VAS. Frequency and percentages were presented for 
categorical variables i.e. gender, post-op pain relief, 
need for post-op analgesia and intensity of pain. Chi-
square test was used to compare pain relief in both 
groups. P-value of < 0.05 was taken as significant. 
Results 
       VAS scores tend to be higher in controls in the 
initial 8hrs of surgery, while they were higher in 
bupivacaine group after 24hrs. Mean VAS scores in 
bupivacaine group at 8, 16 & 24hrs were 4.43, 2.98 & 
1.35 respectively, while they were 6.30, 3.15 &1.43 in 
controls at 8, 16 & 24hrs respectively. (Table 1) 
 
Table 1: Comparison of mean VAS between groups 
Groups VAS (8hrs) 
Mean+SD 
 
VAS(16hrs) 
Mean+SD 
 
VAS(24hrs) 
Mean+SD 
A(n=40) 4.43u+1.2 2.98+1.10 1.35+1.25 
B(n=40) 6.30+1.81 3.15+1.35 1.43+1.06 
     Pain intensity was milder initially during 1st 8hrs in 
bupivacaine group as compared to controls. (Table 2). 
In bupivacaine group 13 patients had mild pain, while 
27 had moderate-severe pain after 1st 8hrs while in 
controls 6 patients had mild pain, while 34 had 
moderate-severe pain after 1st 8hrs. Pain scores and 
intensity was higher in controls with no significant 
difference between both groups 24hrs after surgery. 08 
patients had no pain after 24hrs in bupivacaine group, 
while 06 patients in controls had no pain after 24hrs. 
32 patients in bupivacaine group and 34 patients in 
controls had mild-moderate pain 24hrs after 
surgery.VAS scores tend to be higher in females (mean 
VAS at 8, 16 and 24 hrs was 5.83, 3.00 and 1.19 
respectively) as compared to males (mean VAS at 8, 16 
and 24 hrs was 5.06, 2.65 and 1.24 respectively).Need 
for post-op analgesia in 1st 8hrs was slightly more in 
the controls i.e. 85% (34 patients), while it was 70% in 
bupivacaine group (Table 3).  
 
Table 2: Comparison of pain intensity 
  Pain intensity 
Groups Grading 8hrs 16hrs 24hrs 
A (n=40) No pain 0 0 0 
Mild 13(27.5%) 30(75%) 30(75%) 
Moderate 23(62.5%) 10(25%) 02(5%) 
Severe 04(10%) 0 0 
B (n=40) No pain 0 0 06 (15%) 
Mild 06 (15%) 33 (82.5%) 31 (77.5%) 
Moderate 29 (72.5%) 07(17.5%) 03 (7.5%) 
Severe 05 (12.5%) 0 0 
 
Table 3: Need for additional post-op analgesia  
in both groups 
Time after surgery Groups Yes No(%) 
After 8 hours 
 
A 28 (70%) 12 (30%) 
B 34 (85%) 06 (15%) 
After 16 hours A 10 (25%) 30 (75%) 
B 7 (17.5%) 33 (82.5%) 
After 24 
Hours 
A 2 (5%) 38 (95%) 
B 3 (7.5%) 37 (92.5%) 
 
  The need for post-op analgesia at 16hrs and 24hrs 
after surgery was almost equal in both groups. It was 
25% in bupivacaine group vs. 17.5% in controls at 
16hrs, and 5% in bupivacaine group vs. 7.5% in 
controls at 24hrs after surgery. (Table 3) 
    Need for additional post-op analgesia indirectly 
reflects the post-op pain relief at the corresponding 
time after surgery. In our study the post-op pain relief 
in 1st 8hrs was better in the bupivacaine group i.e. 30% 
(bupivacaine group) vs. 15% (controls), but this 
difference was not statistically significant with a p-
value of 0.108. The post-op pain relief at 16hrs and 
24hrs after surgery was almost equal in both groups, it 
is 75% in bupivacaine group vs. 82.5.5% in controls at 
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16hrs, and 95% in bupivacaine group vs. 92.5% in 
controls at 24hrs after surgery and this difference was 
also not statistically significant with a p-value of 0.412 
and 0.644 respectively at 16 & 24hrs. (Table 4) 
 
Table 4: Post-op pain relief in both groups 
Time after 
surgery 
 
Groups 
 
Poor 
 
Good 
Pearson 
chi-square 
test 
After 8 hours 
 
*A 70% 30%  
0.108 **B 85% 15% 
After 16 hours *A 25% 75%  
0.412 **B 17.5% 82.5% 
After 24 
Hours 
*A 5% 95% 0.644 
 **B 7.5% 92.5% 
*A: Bupivacaine group;**B: Control group 
 
Discussion 
   Since the evolution of laparoscopic cholecystectomy 
in 1980s, this procedure has replaced open 
cholecystectomy all over the world because of its less 
post operative pain, early mobilization, and less post 
operative hospital stay. 6 The technique of laparoscopic 
cholecystectomy which was difficult to learn in its 
evolving phase, had led the surgeons to put conditions 
like acute cholecystitis into contraindications while 
performing laparoscopic cholecystectomy in the past. 
As the technique flourished, surgeons started 
performing laparoscopic cholecystectomy in acute 
phase of cholecystitis as well. 7 Laparoscopic 
cholecystectomy is the treatment of choice for 
symptomatic cholelithiasis. Although there are clear 
benefits compared with open surgery, postoperative 
pain after laparoscopic cholecystectomy remains an 
issue. Pain can prolong hospital stay and lead to 
increased morbidity, which is particularly important 
now that many centers are performing this operation 
as a day-case procedure.  
     Evidence suggests that females have a lower pain 
threshold and a lower tolerance to painful stimuli. 9 A 
meta-analysis of 24 studies revealed  there was a 
significant improvement in postoperative pain relief 
after instillation of intra-peritoneal LA. 10 Although 
statistically significant, this is slightly lower than the 
difference found in a meta-analysis published in 
2000.11 This previous review reported improved pain 
relief in 7 of 13 trials in favor of the treatment groups. 
However, they could not find a significant effect of 
intra-peritoneal LA on the total amount of analgesia 
delivered in the postoperative period. This might be 
explained by the fact that LA has its effects only over 
the initial few hours.10 
    Need for additional post-op analgesia indirectly 
reflects the post-op pain relief at the corresponding 
time after surgery. According to our study the post-op 
pain relief in 1st 8hrs is better in the bupivacaine group 
i.e. 30% (bupivacaine group) vs. 15% (controls), but 
this difference is not statistically significant (p-value of 
0.108). The post-op pain reliief at 16hrs and 24hrs after 
surgery is almost equal in both groups, it is 75% in 
bupivacaine group vs. 82.5.5% in controls at 16hrs, and 
95% in bupivacaine group vs. 92.5% in controls at 
24hrs after surgery and this difference is also not 
statistically significant with a p-value of 0.412 and 
0.644 respectively at 16 & 24hrs. 
     Bisgaard et alapplied a near-maximum dose of local 
anesthetic or placebo in a randomized trial.12 
Ropivacaine (or saline) was infiltrated into the port 
incisions and ropivacaine (or saline) at several sites 
intra-peritoneally. Both treatment groups were given 
NSAIDs and acetaminophen in fixed doses and 
opioids when needed. The local anesthetic regimen 
significantly reduced incisional pain during the first 3 
hours postoperatively.  No analgesic benefits on 
visceral pain or shoulder pain were found, but overall 
pain was significantly reduced during the first 2 
postoperative hours and opioid requirements were 
decreased during the first 3 postoperative hours. The 
findings were later replicated in by Lee et al  in a trial 
of low methodologic quality, stating that there were no 
analgesic differences between incisional versus intra-
peritoneal local anesthetic regimens.13In a study by 
Rehan AG et al (2010) found that infiltration of 0.25% 
bupivacaine at port sites, under the right hemi 
diaphragm and gall bladder bed decreased the post 
operative pain in first 24 hours. It also significantly 
reduced the analgesic requirements in the 
postoperative period in first 24 hours.14 The results of 
the study by Bhardwaj et al (2002)demonstrated that 
intra-peritoneal instillation of bupivacaine with 
adrenaline produces lower VAS up to 8 hours 
postoperatively whereas it produces lower VRS up to 
4 hrs postoperatively. The postoperative analgesic 
requirements are also less but there is no difference in 
the shoulder pain between the two groups.15 
     According to the above discussion, factors which 
may influence the intra-peritoneal analgesia are dose 
and concentration of local anesthesia, site of 
instillation (sub- diaphragmatic vs. sub-hepatic/ gall 
bladder fossa), timing of instillation ( before vs. after 
surgery),pneumo-peritoneum (volume, pressure, 
temperature),volume of residual CO2 (causing 
diaphragmatic irritation),spillage of blood and bile 
(may interfere with absorption),degree of non-visceral 
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pain (e.g. from incision site) and post-operative 
analgesia regimen. 
 
Conclusion 
1. The early post-op VAS scores and pain intensity is 
decreased with the use of intra-peritoneal instillation 
of injection Bupivacaine, but it offers no added benefit 
to the post-operative pain relief and does not decrease 
the need for analgesia post-operatively.  
2. There is no statistical difference between 
conventional intra-muscular post-op analgesia and 
instillation of injection Bupivacaine in gall bladder 
fossa on pain relief and use of analgesia after 
laparoscopic cholecystectomy according to our study.  
 
References 
1. Chiang KW, Lee FM, Santen S, Cholelithiasis, emedicine 
online, june 2010. 
2. Bona S, Monzani R, Fumagalli Romario U. Outpatient 
laparoscopic cholecystectomy: a prospective study of 250 
patients, Gastroenterol Clin Biol  2007;31:1010-15. 
3. Wills V.L and Hunt D.R, Pain after laparoscopic 
cholecystectomy, Bri Jo Surg. 2006; 87: 273 – 84. 
4. Ahmed BH, Ahmed A, Tan D, Awad ZT. Post-laparoscopic 
cholecystectomy pain: effects of intraperitoneal local 
anesthetics on pain control. Am surg. 2008 ;74 : 201-09 
5. Louizos A.A, Hadzilia. S.J, Leandros E. Postoperative pain 
relief after laparoscopic cholecystectomy:A placebo-
controlled double-blind randomized trial of preincisional 
infiltration and intraperitoneal instillation of 
levobupivacaine 0.25%, Surgical Endoscopy.  2005; 
19:1503-36 
6. Paul FW. The Role of Non-Opioid Analgesic Techniques in 
the management of pain after ambulatory surgery; white 
anesth analg non-opioid analgesics and postoperative pain 
2002;94:577–85 
7. Esmat ME, Magdy MA, Elsebae, Magid MA. Combined Low 
Pressure Pneumoperitoneum and Intraperitoneal Infusion of 
Normal Saline for Reducing Shoulder Tip Pain Following 
Laparoscopic Cholecystectomy World Jo Surg 2006; 30(11): 
1969-73 
8. Thue B. Analgesic Treatment after Laparoscopic 
Cholecystectomy: A Critical Assessment of the Evidence; 
Anesthesiology April 2006;104(4) 835-46 
9. Uchiyama K, Kawai M, Tani, M. Ueno T. Gender differences 
in postoperative pain after laparoscopic cholecystectomy 
,Surgical Endoscopy. 2006;2: 448-51 
10. Boddy PA, Mehta S, Rhodes M; The Effect of intra-peritoneal 
local anesthesia in laparoscopic cholecystectomy. Anesth 
Analg 2006.    
11. Moiniche S, Jorgensen H, Wetterslev J. Local anesthetic 
infiltration for postoperative pain relief after laparoscopy: a 
qualitative and quantitative systematic review of 
intraperitoneal, port-site infiltration and mesosalpinx block. 
Anesth Analg 2000;90:899–912. 
12. Bisgaard T, Klarskov B, Kristiansen VB, Callesen T.Multi-
regional local anesthetic infiltration during laparoscopic 
cholecystectomy in patients receiving prophylactic multi-
modal analgesia: A randomized, double-blinded, placebo-
controlled study. Anesth Analg 1999; 89:1017–24 
13. Lee IO, Kim SH, Kong MH, Lee MK, Kim NS. Pain after 
laparoscopic cholecystectomy: The effect and timing of 
incisional and intraperitoneal bupivacaine. Can J Anaesth 
2001; 48:545–50 
14. Rehan AG, Ali Z; Post-operative Pain After Laparoscopic 
Cholecystectomy: Role of port site And Intra-Peritoneal 
Infiltration Of Injection Bupivacaine A.P.M.C January-June 
2010;4(1):2751-54 
15. Bhardwaj N, Sharma V,Chari P. Intraperitoneal bupivacaine 
instillation for postoperative pain relief after laparoscopic 
cholecystectomy; Indian J. Anaesth. 2002; 46 (1) : 49-52 
 
